Microvast investors: lead‑plaintiff Sept 21
- Wolf Haldenstein said on September 2 that Microvast investors who bought during the alleged class period face a September 21, 2026 lead-plaintiff deadline. (prnewswire.com) - The proposed class period runs from April 1, 2025 to March 16, 2026, and the suit points to a gross-margin drop to 1%. (prnewswire.com) - September 21, 2026 is the date for investors to ask the court to appoint a lead plaintiff. (businesswire.com)
Wolf Haldenstein Adler Freeman & Herz LLP said on September 2 that investors who lost money in Microvast Holdings shares may seek appointment as lead plaintiff in a securities fraud class action by September 21, 2026. The notice follows similar reminders from other plaintiffs’ firms in August tied to the same proposed case against the battery maker. The lawsuit covers investors who bought Microvast securities between April 1, 2025 and March 16, 2026, according to the law-firm notices. (prnewswire.com) The case centers on allegations that Microvast misled investors about margin targets, inventory conditions and the timing of a manufacturing expansion in Huzhou, China. Microvast’s March 16, 2026 Form 8-K reported fourth-quarter and full-year 2025 results, a disclosure date cited in the proposed class period end. (businesswire.com) The allegations in the lawsuit have not been proven in court. ### Who is covered by the proposed class? The proposed class includes investors who purchased or acquired Microvast common stock or other securities between April 1, 2025 and March 16, 2026, according to Wolf Haldenstein and Kirby McInerney notices. Those investors may remain absent class members if a class is certified, or they may ask the court to appoint them lead plaintiff if they want a larger role in the case. (prnewswire.com) Kirby McInerney said the court will not consider lead-plaintiff applications filed after September 21, 2026. Law-firm notices say the lead plaintiff oversees the litigation on behalf of the class and may influence strategy and settlement discussions. (prnewswire.com) ### What are the plaintiffs alleging Microvast got wrong? The complaint alleges Microvast overstated its ability to reach margin targets because of inventory-management issues and delays in commercial vehicle rollouts by customers, according to the Wolf Haldenstein and Kirby McInerney notices. The filings also allege the company overstated its ability to complete the Huzhou Phase 3.2 expansion and bring added capacity online by the end of 2025. (prnewswire.com) Wolf Haldenstein’s notice said defendants also failed to disclose facts that allegedly made prior public statements materially false or misleading. Those assertions come from plaintiffs’ allegations in the complaint, not findings by a judge. (businesswire.com) ### Which disclosures are cited as stock-drop events? June 25, 2025 is identified in Wolf Haldenstein’s notice as the date the market got a “first hint” of the alleged problems, after short seller Grizzly Research published a report on Microvast. Wolf Haldenstein said the stock fell as much as $0.40 intraday, or about 10.23%, before closing at $3.90 that day. August 1, 2025 is another date cited in the litigation notices, when Microvast announced the departure of Chief Financial Officer Carl T. (prnewswire.com) Schultz, about three months after he joined the company. Kirby McInerney said the shares fell $0.30, nearly 10%, to close at $2.72 on August 4, 2025. November 10, 2025 is cited in the notices as the date Microvast said production after the Huzhou Phase 3.2 expansion would begin in the first quarter of 2026 rather than the fourth quarter of 2025. Kirby McInerney said the stock fell $0.50, about 10%, to close at $4.48 on November 11, 2025. (prnewswire.com) ### Why does March 16, 2026 matter in the case? March 16, 2026 is the end of the proposed class period in the law-firm notices and the date Microvast filed an 8-K reporting fourth-quarter and full-year 2025 results. Kirby McInerney said the company reported gross margin of about 1% for the quarter, down from about 36% a year earlier, which it attributed to inventory impairment charges tied to “specialized ESS components.” (businesswire.com) Microvast’s investor-relations site also shows a May 27, 2026 8-K disclosing that Chief Accounting Officer Eric N. Garcia had ceased to be employed by the company and that Chief Executive Officer Yang Wu converted a $25 million loan into common stock. That filing is separate from the alleged class period but forms part of the company’s more recent disclosure record. (businesswire.com) ### What happens next for investors? September 21, 2026 is the next concrete deadline in the case. Investors who want to seek lead-plaintiff status must ask the court for appointment by that date, according to notices from Wolf Haldenstein, Kirby McInerney and other firms circulating in August and September. (prnewswire.com) (ir.microvast.com) (businesswire.com)